Evidence map›Paper›PMID 42185999›Full record

ArticleBMC pediatrics2026

Echocardiographic assessment of cardiac involvement in pediatric COVID-19 patients: a cross-sectional study.

Mohammad Reza Khalilian, Aliahmad Goudarzi, Abdollah Karimi, Alireza Fahimzad, Kourosh Vahidshahi, Fariba Alaei, Tahmineh Tahouri

Abstract read
In one paragraph

Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad Reza KhalilianDepartment of Pediatrics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-6365-2530
Aliahmad GoudarziDepartment of Pediatrics, Shahid Beheshti University of Medical Science, Tehran, Iran.ORCID 0009-0009-9117-3495
Abdollah KarimiPediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-4225-0097
Alireza FahimzadPediatric Infectious Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-6054-0656
Kourosh VahidshahiPediatric Cardiology Ward, Modarres Teaching Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-3618-1697
Fariba AlaeiDepartment of Pediatric Cardiology, Mofid Children's Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran.ORCID 0000-0003-3220-8618
Tahmineh TahouriCardiovascular Research Center, Rajaie Cardiovascular Institute, Valiasr Ave., Niayesh Intersection, Tehran, 1995614331, Iran. tahmineh.tahouri@hotmail.com.ORCID 0000-0001-7554-7770

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac involvement has emerged as a significant complication in children with COVID-19, particularly in those with multisystem inflammatory syndrome in children (MIS-C). However, systematic echocardiographic data remain limited, especially from the Middle East.

methodsIn this descriptive cross-sectional study, 433 children with confirmed COVID-19 admitted to a tertiary hospital in Tehran were evaluated. Transthoracic echocardiography was performed in all patients during hospitalization. Cardiac function, valvular regurgitation, pericardial and pleural effusion, and coronary artery dimensions (Z-score-based) were recorded. Findings were compared between MIS-C and non-MIS-C patients.

resultsAmong 433 patients (mean age 4.56 years; 54% male), 270 (62.5%) were diagnosed with MIS-C. The most common echocardiographic abnormalities were mitral regurgitation (19.4%) and pericardial effusion (18.5%). Coronary abnormalities (1.4%) and LV systolic dysfunction (4.8%) were uncommon. MIS-C patients had significantly higher rates of pericardial effusion (23% vs. 11%, p = 0.002). Pericardial effusion was the only variable significantly associated with ICU admission (p = 0.002). Pleural effusion was observed only in non-MIS-C patients (3.1%, p = 0.003).

conclusionsEchocardiographic abnormalities are common in children hospitalized with COVID-19, particularly those with MIS-C. Pericardial effusion may serve as an early marker of severity and guide triage. Routine cardiac imaging is recommended in hospitalized children with inflammatory symptoms.

Indexed as

COVID-19EchocardiographyHeart DiseasesChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantIranMaleMitral Valve InsufficiencyPandemicsPericardial EffusionPleural EffusionSARS-CoV-2Cardiac Imaging TechniquesChildCOVID-19EchocardiographyMultisystem Inflammatory Syndrome in ChildrenMyocarditisPediatricsVentricular Dysfunction

Identifiers

PMID42185999
PMCPMC13393798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.